Principal Investigator
Debra Kelsh, MD
Vince and Associates Clinical Research
- 6 trials
- 1 compound
Therapeutic focus
- Cocaine Use Disorder
- Opioid Use Disorder
- Opioid-use Disorder
- Cannabis Use Disorder
All trials (6)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06343532 | Phase 1 | Completed | — | National Institute on Drug Abuse (NIDA) |
| NCT06273540 | Phase 1 | Completed | Mavoglurant | Stalicla SA |
| NCT05587998 | Phase 1 | Completed | — | AstraZeneca |
| NCT03386591 | Phase 1 | Completed | — | National Institute on Drug Abuse (NIDA) |
| NCT03398083 | Phase 1 | Completed | — | National Institute on Drug Abuse (NIDA) |
| NCT02856854 | Phase 1 | Completed | — | Embera NeuroTherapeutics, Inc. |
Compounds studied
Trial sites (1)
- Overland Park, Kansas, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).